Skip to content

Clinical trials

Small Cell Lung Carcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Country / region: United States Clear all

601 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200019
200111
200214
200311
200417
200515
200621
200722
200815
200920
201015
201113
201215
201314
201417
201516
201621
201731
201831
201926
202037
202130
202224
202323
202415
202537
202634

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed291
Terminated110
Recruiting99
Active, not recruiting65
Unknown status15
Withdrawn11
Suspended4
Not yet recruiting3
No longer available1
Enrolling by invitation1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)56
Amgen16
AbbVie14
Memorial Sloan Kettering Cancer Center13
AstraZeneca11
GlaxoSmithKline10
Case Comprehensive Cancer Center9
M.D. Anderson Cancer Center9
Pfizer9
Alliance for Clinical Trials in Oncology8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma601
Carcinoma, Non-Small-Cell Lung231
Lung Neoplasms199
Breast Neoplasms72
Stomach Neoplasms72
Ovarian Neoplasms65
Neoplasms61
Carcinoma, Renal Cell60
Melanoma60
Pancreatic Neoplasms60

Trials

Showing 1 to 25 of 601. Each trial links to its page on Pharma Observatory.

501 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.